share_log

EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans

EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans

獨家:Ayahuasca Pill 正式上市,Filament 首席執行官討論未來計劃
Benzinga Real-time News ·  2022/12/15 12:51
Part one of a three-part series.
由三部分組成的系列的第一部分。
The first medical-grade drug candidate of the psychedelic ayahuasca is being developed.
迷幻 ayahuasca 的第一個醫療級候選藥物正在開發中。
Currently in the form of a pill, the compound was conceived by Vancouver, BC-based natural drug development company Filament Health (OTC:FLHLF).
目前以 a 的形式 丸,該化合物由總部位於不列顛哥倫比亞省溫哥華的天然藥物開發公司構思 燈絲健康 (場外:FLHLF)。
During the development process, questions arose:
在開發過程中,出現了以下問題:
What exactly constitutes a dose when discussing a drug typically used within religious contexts? What's the need of the drug-induced trip experience (and the typical pre-trip nausea) for obtaining health benefits? How can Filament actually perform drug development tasks in a responsible manner facing ayahuasca's sacramental essence...
在討論通常在宗教背景下使用的藥物時,究竟甚麼構成劑量? 藥物引起的旅行經歷(以及典型的旅行前噁心)需要...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論